JP2014502961A5 - - Google Patents

Download PDF

Info

Publication number: JP2014502961A5
Authority: JP; Japan
Prior art keywords: seq; composition; peptide; peptides; prostate cancer
Prior art date: 2011-11-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2013543601A

Other languages

English (en)

Japanese (ja)

Other versions

JP2014502961A (ja

JP6032853B2 (ja

Filing date

2011-11-14

Publication date

2014-12-25

2010-12-14 Priority claimed from PCT/EP2010/069675 external-priority patent/WO2011073215A2/en

2011-11-14 Application filed filed Critical

2011-11-14 Priority claimed from PCT/EP2011/070024 external-priority patent/WO2012079878A2/en

2014-02-06 Publication of JP2014502961A publication Critical patent/JP2014502961A/ja

2014-12-25 Publication of JP2014502961A5 publication Critical patent/JP2014502961A5/ja

2016-11-30 Application granted granted Critical

2016-11-30 Publication of JP6032853B2 publication Critical patent/JP6032853B2/ja

Status Expired - Fee Related legal-status Critical Current

2031-11-14 Anticipated expiration legal-status Critical

Links

239000000203 mixture Substances 0.000 claims 18
108090000765 processed proteins & peptides Proteins 0.000 claims 18
102000004196 processed proteins & peptides Human genes 0.000 claims 8
206010060862 Prostate cancer Diseases 0.000 claims 6
208000000236 Prostatic Neoplasms Diseases 0.000 claims 6
239000003098 androgen Substances 0.000 claims 5
239000002671 adjuvant Substances 0.000 claims 3
125000003275 alpha amino acid group Chemical group 0.000 claims 3
239000003814 drug Substances 0.000 claims 3
229940124597 therapeutic agent Drugs 0.000 claims 3
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
210000004443 dendritic cell Anatomy 0.000 claims 2
238000002560 therapeutic procedure Methods 0.000 claims 2
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
102000006354 HLA-DR Antigens Human genes 0.000 claims 1
108010058597 HLA-DR Antigens Proteins 0.000 claims 1
101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims 1
239000000427 antigen Substances 0.000 claims 1
210000000612 antigen-presenting cell Anatomy 0.000 claims 1
102000036639 antigens Human genes 0.000 claims 1
108091007433 antigens Proteins 0.000 claims 1
108020001507 fusion proteins Proteins 0.000 claims 1
102000037865 fusion proteins Human genes 0.000 claims 1
229960002751 imiquimod Drugs 0.000 claims 1
DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
108010028930 invariant chain Proteins 0.000 claims 1
239000003970 toll like receptor agonist Substances 0.000 claims 1
229940044616 toll-like receptor 7 agonist Drugs 0.000 claims 1

JP2013543601A 2010-12-14 2011-11-14 前立腺関連抗原分子由来ｈｌａ結合ペプチドおよびその使用方法 Expired - Fee Related JP6032853B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/EP2010/069675 WO2011073215A2 (en)	2009-12-14	2010-12-14	Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
EPPCT/EP2010/069675		2010-12-14
PCT/EP2011/070024 WO2012079878A2 (en)	2010-12-14	2011-11-14	Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof

Publications (3)

Publication Number	Publication Date
JP2014502961A JP2014502961A (ja)	2014-02-06
JP2014502961A5 true JP2014502961A5 (ru)	2014-12-25
JP6032853B2 JP6032853B2 (ja)	2016-11-30

Family

ID=44983532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2013543601A Expired - Fee Related JP6032853B2 (ja)	2010-12-14	2011-11-14	前立腺関連抗原分子由来ｈｌａ結合ペプチドおよびその使用方法

Country Status (9)

Country	Link
JP (1)	JP6032853B2 (ru)
KR (1)	KR20130126671A (ru)
CN (1)	CN103547283A (ru)
AU (1)	AU2011344652B2 (ru)
CA (1)	CA2821582A1 (ru)
MX (1)	MX2013006758A (ru)
NZ (1)	NZ609916A (ru)
SG (1)	SG191154A1 (ru)
WO (1)	WO2012079878A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102013012432A1 (de) *	2013-07-29	2015-01-29	Eberhard Karls Universität Tübingen Medizinische Fakultät	Immuntherapie von Prostatakrebs
ES2910443T3 (es) *	2014-04-16	2022-05-12	Biocon Ltd	Formulaciones de proteínas estables que comprenden un exceso molar de sorbitol
EP3845557B1 (en) *	2015-06-12	2023-08-02	Lentigen Technology, Inc.	Method to treat cancer with engineered t-cells
GB201513921D0 (en) *	2015-08-05	2015-09-23	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
GB201521746D0 (en) *	2015-12-10	2016-01-27	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
GB201602918D0 (en) *	2016-02-19	2016-04-06	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
GB201603987D0 (en)	2016-03-08	2016-04-20	Immatics Biotechnologies Gmbh	Uterine cancer treatments
DE102016123893A1 (de)	2016-12-08	2018-06-14	Immatics Biotechnologies Gmbh	T-Zellrezeptoren mit verbesserter Bindung
NZ754222A (en)	2016-12-08	2022-02-25	Immatics Biotechnologies Gmbh	T cell receptors with improved pairing
BR112019016657A2 (pt) *	2017-02-12	2020-04-07	Neon Therapeutics, Inc.	métodos baseados em hla e composições e usos destes
KR102215578B1 (ko) *	2019-03-28	2021-02-15	한국과학기술연구원	인간 백혈구 항원에 특이적으로 결합하는 펩타이드 및 이의 용도

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA725596A (en)	1960-08-26	1966-01-11	J. Wretlind Arvid	Method of preparing intravenously injectable fat emulsions free from side reactions or complications
US4897445A (en)	1986-06-27	1990-01-30	The Administrators Of The Tulane Educational Fund	Method for synthesizing a peptide containing a non-peptide bond
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US5849589A (en)	1996-03-11	1998-12-15	Duke University	Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US6406705B1 (en)	1997-03-10	2002-06-18	University Of Iowa Research Foundation	Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1244465A4 (en) *	1999-12-21	2005-01-12	Epimmune Inc	INDUCING CELLULAR IMMUNE RESPONSES TO ANTIGENS OF PROSTATE CANCER USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
US6436703B1 (en) *	2000-03-31	2002-08-20	Hyseq, Inc.	Nucleic acids and polypeptides
US20020081680A1 (en) *	2000-04-17	2002-06-27	Jiangchun Xu	Compositions and methods for the therapy and diagnosis of prostate cancer
US7892559B2 (en)	2002-01-30	2011-02-22	Survac Aps	Survivin-derived peptides and use thereof
US20030235533A1 (en) *	2002-02-19	2003-12-25	Idec Pharmaceuticals Corporation	Prostate specific genes and the use thereof in design or therapeutics
AU2003256912A1 (en) *	2002-08-16	2004-03-03	Yeda Research And Development Co. Ltd.	Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
WO2004053075A2 (en) *	2002-12-05	2004-06-24	Diadexus, Inc.	Compositions, splice variants and methods relating to breast specific genes and proteins
WO2005033265A2 (en) *	2003-04-25	2005-04-14	Epimmune Inc.	Optimized multi-epitope constructs and uses thereof
US8435507B2 (en) *	2004-08-19	2013-05-07	University Of Maryland	Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer
PL1642905T3 (pl)	2004-10-02	2009-04-30	Immatics Biotechnologies Gmbh	Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy
SI1806359T1 (sl)	2005-09-05	2010-06-30	Immatics Biotechnologies Gmbh	S tumorjem povezani peptidi ki se vežejo brez izjeme na molekule humanega levkocitnega antigena HLA razred II
PT2113253E (pt) *	2008-04-30	2010-06-15	Immatics Biotechnologies Gmbh	Formulações novas de peptídeos associados a tumores que se ligam a moléculas de classe i ou ii do antígeno leucocitário humano (hla) para vacinas
ES2532896T5 (es) *	2008-05-14	2018-03-20	Immatics Biotechnologies Gmbh	Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan
PT2172211E (pt) *	2008-10-01	2015-03-09	Immatics Biotechnologies Gmbh	Composição de peptídeos associados a tumores e vacina anti -cancro relacionada para o tratamento de glioblastoma (gbm) e outros tipos de câncer

2011
- 2011-11-14 CA CA2821582A patent/CA2821582A1/en not_active Abandoned
- 2011-11-14 JP JP2013543601A patent/JP6032853B2/ja not_active Expired - Fee Related
- 2011-11-14 NZ NZ60991611A patent/NZ609916A/en not_active IP Right Cessation
- 2011-11-14 KR KR1020137018147A patent/KR20130126671A/ko not_active Withdrawn
- 2011-11-14 CN CN201180059274.2A patent/CN103547283A/zh active Pending
- 2011-11-14 SG SG2013045737A patent/SG191154A1/en unknown
- 2011-11-14 AU AU2011344652A patent/AU2011344652B2/en not_active Ceased
- 2011-11-14 WO PCT/EP2011/070024 patent/WO2012079878A2/en not_active Ceased
- 2011-11-14 MX MX2013006758A patent/MX2013006758A/es unknown

Similar Documents

Publication	Publication Date	Title
JP2014502961A5 (ru)	2014-12-25
AR121588A2 (es)	2022-06-22	Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer
PE20240645A1 (es)	2024-04-04	Peptido inmunogenico derivado de moleculas de antigenos leucocitarios humanos (hla) como biomarcador en la inmunoterapia de diversos tumores
EA201892021A1 (ru)	2019-02-28	Трансфицированные t-клетки и t-клеточные рецепторы для применения в иммунотерапии раковых заболеваний
EA201891759A1 (ru)	2019-02-28	Трансфицированные t-клетки и t-клеточные рецепторы для применения в иммунотерапии раковых заболеваний
EP3545965A3 (en)	2019-12-25	Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
JP2018510215A5 (ru)	2019-03-22
EP2562183A8 (en)	2013-05-08	Novel immunogenic epitopes for immunotherapy
CA3033115A1 (en)	2018-03-01	Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers
NZ609916A (en)	2015-03-27	Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
MX2011007963A (es)	2011-08-17	Peptidos neil3 y vacunas que incluyen los mismos.
RU2013158399A (ru)	2015-07-20	Пептиды sema5b и содержащие их вакцины
BR112012018457A2 (pt)	2017-01-10	peptídeos melk modificados e vacinas contendo os mesmos
RU2014109137A (ru)	2015-09-20	Пептиды mphosph1 и вакцины, включающие их
NZ601980A (en)	2014-08-29	Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
EP3208334A3 (en)	2017-10-18	Cdc45l peptides and vaccines including the same
RU2011150283A (ru)	2013-06-20	Пептиды ттк и вакцины, их содержащие
EA201390811A1 (ru)	2013-12-30	Пептиды tomm34 и содержащие их вакцины
MX2020011793A (es)	2020-12-07	Nuevos peptidos y nueva combinacion de peptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cancer.
MX2011008917A (es)	2011-09-09	Peptidos vangl1 y vacunas que incluyen los mismos.
BR112012014345A2 (pt)	2017-01-10	peptídeos tmem22 e vacinas incluindo os mesmos
MY170949A (en)	2019-09-20	A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine
NZ593200A (en)	2012-10-26	Peptide adjuvants
BR112013009526A2 (pt)	2017-05-02	peptídeos de wdhd1 e vacinas incluindo os mesmos
BR112013009276A2 (pt)	2019-09-24	peptídeos de c18orf54 e vacinas incluindo os mesmos